CJC-1295 and ipamorelin is a peptide blend commonly studied for its synergistic effects on stimulating natural growth hormone release. CJC-1295 is a long-acting analog of growth hormone–releasing hormone (GHRH), designed to increase the secretion of growth hormone by extending its half-life in circulation. Ipamorelin is a selective growth hormone secretagogue that mimics ghrelin, promoting growth hormone release without significantly affecting cortisol or prolactin levels.
Researchers investigate this combination for its potential to enhance growth hormone pulsatility, support lean tissue development, and influence metabolic processes such as fat utilization and recovery mechanisms. The blend is also examined for its effects on insulin-like growth factor 1 (IGF-1) levels and overall endocrine system modulation in controlled laboratory environments.
This compound is intended strictly for laboratory research purposes only and is not for human consumption or veterinary use.